Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 4

Research Article

Acupoint Embedding of Polyglactin 910 Sutures in Patients with Chronic Pain due to Cervical Spondylotic Radiculopathy: A Multicenter, Randomized, Controlled Clinical Trial

Table 4

Secondary outcome measures (quality of life assessment).

Outcome MeasureSAE
(n = 34)
MAPE
(n = 34)
DAPE
(n = 34)
Tukey’s Comparison
MAPE vs. SAE DAPE vs. SAE DAPE vs. MAPE
Diff. (95% CI)PDiff. (95% CI)PDiff. (95% CI)P

The Physical Component Summary (PCS) of the SF36 health questionnaire, Mean ± SD
Baseline56.4 ± 13.854.4 ± 13.857.4 ± 19.8−2.0 (−10.1 to 6.1)>.050.9 (−7.1 to 9.0)>.053.9 (−5.1 to 12.9)>.05
T 1w56.9 ± 14.658.0 ± 14.459.8 ± 19.21.1 (−7.0 to 9.2)>.052.9 (−5.2 to 10.9)>.052.8 (−6.3 to 11.8)>.05
T 2w56.3 ± 14.568.9 ± 11.869.3 ± 13.812.6 (4.5 to 20.7)<.00113.0 (4.9 to 21.1)<.0011.6 (−7.5 to 10.6)>.05
T 3w56.7 ± 13.5666.7 ± 11.475.7 ± 12.710.0 (1.9 to 18.1)<.0519.0 (11.0 to 27.1)<.00110.1 (1.0 to 19.1)<.05
F 4w57.0 ± 14.569.9 ± 11.869.0 ± 15.412.9 (4.8 to 21.0)<.00111.9 (3.9 to 20.0)<.010.4 (−7.4 to 8.2)>.05
F 10w57.7 ± 13.975.2 ± 9.374.2 ± 13.117.5 (9.4 to 25.6)<.00116.5 (8.4 to 24.6)<.001−0.4 (−8.2 to 7.3)>.05
P(t)0.129<.001<.001NA
The Mental Component Summary (MCS) of the SF36 health questionnaire, Mean ± SD
Baseline55.7 ± 13.354.8 ± 14.656.9 ± 15.9−0.9 (−8.2 to 6.4)>.051.2 (−6.1 to 8.5)>.052.1 (−5.2 to 9.4)>.05
T 1w57.9 ± 11.661.1 ± 17.463.4 ± 18.03.1 (−4.2 to 10.5)>.055.4 (−1.9 to 12.8)>.052.3 (−5.0 to 9.6)>.05
T 2w57.0 ± 11.676.6 ± 11.377.8 ± 11.519.6 (12.3 to 26.9)<.00120.8 (13.5 to 28.1)<.0011.1 (−6.2 to 8.5)>.05
T 3w57.3 ± 11.075.6 ± 8.976.9 ± 10.118.4 (11.1 to 25.7)<.00119.6 (12.3 to 26.9)<.0011.2 (−6.1 to 8.5)>.05
F 4w58.2 ± 12.263.3 ± 13.563.1 ± 10.95.0 (−2.3 to 12.4)>.054.9 (−2.4 to 12.2)>.05−0.1 (−7.4 to 7.2)>.05
F10w58.7± 11.762.8 ± 11.164.5 ± 12.14.1 (−3.2 to 11.4)>.055.8 (−1.5 to 13.1)>.051.7 (−5.6 to 9.0)>.05
P(t)0.058<.001<.001NA

SAE, sham acupoint embedding group; MAPE, middle-layer (the semispinalis capitis muscle layer) PGLA embedding group; DAPE, deep-layer (the multifidus muscle layer) PGLA embedding group; CI, confidence interval; NA, not applicable. 1w, 1 week; 2w, 2 weeks; 3w, 3 weeks; 4w, 4 weeks; 10w, 10 weeks; T, treatment; F, follow-up. P(t) refers to the p-values between different treatment time points.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.